CONSOLIDATED INCOME STATEMENT for the nine months ended 31 December 2016 9 months 12 months ended ended 31 December 31 March 2016 2016 Note m m Revenue 3 126.5 72.0 Cost of sales 41.9 3.3 Gross profit 84.6 68.7 Selling and marketing expenses 2.8 Research and development expenses 5 45.6 42.1 Corporate and administrative expenses 7.0 4.8 Share-based payments 6 1.8 2.5 Other income 1.5 Operating profit before exceptional items and amortisation 28.9 19.3 Amortisation of intangible assets 6 64.0 18.8 Exceptional items 9 9.4 5.6 Loss after exceptional items and amortisation 44.5 5.1 Net finance income 10 4.0 3.8 Share of movements in associate 0.4 0.6 Loss before taxation 40.1 1.9 Net taxation credit 11 8.0 6.9 Loss profit after taxation 32.1 5.0 EBITDA 6 34.1 23.2 Loss earnings per share Basic 12 5.3p 1.2p Diluted 12 5.3p 1.2p EBITDA per share Basic 12 5.6p 5.7p Diluted 12 5.6p 5.6p All results are attributable to shareholders and are derived from continuing operations.
An all-share merger with Skyepharma PLC Skyepharma was completed on 10 June 2016, after which the results of Skyepharma are incorporated in to the Groups reported results.
A shortened nine-month period is presented to align the accounting reference dates of the Merged Group.
Comparative disclosures forthetwelve-month period ended 31 March 2016 reference the latest audited Vectura Group plc Annual Report and Accounts.
To support review of trends in performance, certain unaudited proforma information is presented within the Financial Review.
EBITDA represents operating profit before exceptional items and amortisation, adding back share-based payments and depreciation.
98 Vectura Group plc Report and Accounts for the nine-month period ended 31 December 2016 FINANCIAL STATEMENTS CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME for the nine months ended 31 December 2016 9 months 12 months ended ended 31 December 31 March 2016 2016 m m Loss profit after taxation 32.1 5.0 Net foreign exchange gain arising from translating foreign operations 49.0 5.4 Actuarial gains on re-measurement of pensions 1.1 Other comprehensive income 50.1 5.4 Total comprehensive income 18.0 10.4 All results are attributable to shareholders and are derived from continuing operations.
All items presented above are net of deferred tax and may be reclassified to profit or loss in subsequent years.
On 23 June 2016, the United Kingdom held a referendum and voted to leave the European Union.
Sterling weakened against a number ofcurrencies, including the functional currencies of the Groups principal overseas operations the US Dollar, Swiss Franc and Euro.
Asthese consolidated financial statements are presented in Sterling, a 49.0m foreign exchange gain was recognised on translating overseas subsidiaries into the presentation currency.
Report and Accounts for the nine-month period ended 31 December 2016 Vectura Group plc 99
